Archive Newsletter

31. 09.24.25 -- Advancing Communication And Consistency In CGT Regulation 9/24/2025
    09/24/25 Cell & Gene Newsletter
32. 09.23.25 -- Optimizing Lentiviral Vectors For Allogeneic CAR-T Manufacturing 9/23/2025
    09/23/25
33. 09.23.25 -- STREAM Edition: Engineering Off-The-Shelf Cell Therapies For Cancer And Autoimmune Disease 9/23/2025

    09/23/25 Cell & Gene Newsletter

34. 09.22.25 -- How AbbVie's Digital Transformation Brought Platform Knowledge Closer 9/22/2025
    09/22/25 Cell & Gene Newsletter
35. 09.19.25 -- Gene Therapy For Inherited Retinal Diseases 9/19/2025
    09/19/25 Cell & Gene Newsletter
36. 09.18.25 -- Bottled Potential: Why Automation Beats Manual Bottle Filling 9/18/2025

    09/18/25 Cell & Gene Newsletter

37. 09.18.25 -- Contract Manufacturing Outsourcing Trends For Advanced Therapies In 2025 And Beyond 9/18/2025
    09/18/25 Cell & Gene Newsletter
38. 09.17.25 -- Building Modularity Into Your Biopharmaceutical Production 9/17/2025

    09/17/25 Cell & Gene Newsletter

39. 09.17.25 -- Developing Interleukin-2 For Cell Therapies: Key Considerations 9/17/2025
    09/17/25 Cell & Gene Newsletter
40. 09.16.25 -- Reimagining the future of aseptic filling 9/16/2025

    09/16/25 Cell & Gene Newsletter